Global Information
회사소개 | 문의 | 비교리스트

중수소화 제제 치료 시장 전략

Deuterated Drugs Formulations Therapeutics Markets Strategies

리서치사 Greystone Research Associates
발행일 2017년 08월 상품 코드 539022
페이지 정보 영문
US $ 3,850 ₩ 4,680,000 PDF by E-mail (Single User License)
US $ 5,500 ₩ 6,685,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 9,117,000 PDF by E-mail (Global License)

중수소화 제제 치료 시장 전략 Deuterated Drugs Formulations Therapeutics Markets Strategies
발행일 : 2017년 08월 페이지 정보 : 영문

중수소화 제제(Deuterated Drugs) 치료 시장에 대해 조사했으며, 현재 FDA 인가를 받은, 또는 후기 개발 단계의 중수소화 제제, 그 특징, 출시 경위 및 치료 특징, 중수소화 제제의 개발을 촉진하는 주요 요인, 중수소화 제제 디벨로퍼의 제품 전략, 현재 시장 규모 및 주요 기업 등의 정보를 전해드립니다.

1. 주요 요약

2. 중수소화 제제 치료

  • 제제 설계 기술
  • 약제 특징
  • 투여 간격 확장
  • 치료제의 미충족 요구에 대응

3. 주요 단기적 치료 목표

  • 신경전달물질 조정
  • 막투과 전도
  • 키나아제 저해제
  • 항염증제
  • 미토콘드리아 기능 제어
  • 항신생물제

4. 중수소화 제제 : 단기적인 치료 시장 분석

  • 중독
  • 자가면역질환
  • 유전성 질환
  • 신경성 질환
  • 안과 질환

5. 시장 요인

  • 규제와 인가
  • 임상시험과 엔드포인트
  • IP/특허 요인
  • 방어적 특허 전략
  • 의료 경제학

6. 기업 개요

KSM 17.08.24

Deuterated Drugs: Products, Pipelines, Strategies, Therapeutics and Markets is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug formulation developers, product designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for drugs that incorporate deuterium into the chemical structure of APIs to modify drug properties in vivo. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Deuterated Drugs - What You Will Learn

  • What deuterated drugs are currently FDA-approved or in late-stage development, what are their distinguishing properties, how are they marketed, and what are the therapeutic specifics?
  • What are the major factors driving the development of deuterated drugs?
  • What are the product strategies of deuterated drug developers?
  • What is the size of the deuterated drug market today, who are the active sector participants, and what will the market look like in 2024?
  • How important are formulator-developer-manufacturer relationships and what are the key alliances in the industry?
  • What are the significant economic, technology, and regulatory factors affecting the market for deuterated drugs?

Table of Contents

Executive Summary

  • Drug Therapy Market Dynamics
  • Market Segments and Indications
  • Competing Technologies
  • Market Drivers
  • Drug Re-positioning/Re-purposing
  • Extending Patent Life
  • Dosing Frequency & Patient Adherence
  • Competitive Landscape
  • Formulators/Developers
  • Marketers
  • Alliances
  • Acquisitions

Deuterated Drug Therapeutics

  • Formulation Technology
  • Drug Property Kinetics
  • Extending Dosing Intervals
  • Addressing Unmet Therapeutic Needs

Selected Near-term Therapeutic Targets

  • Neurotransmitter Regulation
  • Transmembrane Conductance
  • Kinase Inhibitors
  • Anti-inflammatory
  • Mitochondrial Function Modulation
  • Antineoplastic

Deuterated Drugs - Near-term Therapeutic Market Analysis

  • Addiction
  • Autoimmune Diseases
  • Hereditary
  • Neurology
  • Oncology
  • Ophthalmology

Market Factors

  • Regulations and Approvals
  • Clinical Trials & End Points
  • IP/Patent Factors
  • Defensive Patent Strategies
  • Healthcare Economics

Company Profiles

Back to Top
전화 문의